Skip to main content

$0.095 0.002 (2.15%)

High

$0.10

Low

$0.10

Trades

1

Turnover

$475

Volume

5,000
30 June 2023 at 12:12pm
Register to track ILA and receive email alerts.
Subject
ILA Ann: Island receives FDA go-ahead for ISLA-101 program

ILA Ann: Replacement - Change in substantial holding

ILA Ann: Change in substantial holding

ILA Ann: Quarterly Activity Report & Appendix 4C

ILA Ann: Island submits responses to FDA questions for ISLA-101

ILA Ann: Application for quotation of securities - ILA

ILA Ann: Appendix 3Y - Albert Hansen

ILA Ann: Notification of cessation of securities - ILA

ILA Ann: Release of Securities from Escrow

ILA Ann: Appendix 4D & Half-Year Financial Statements

ILA Ann: Change in substantial holding

ILA Ann: ILA receives additional FDA feedback on IND for ISLA 101

ILA Ann: Quarterly Activity Report & Appendix 4C

ILA Ann: Island receives FDA feedback on Phase 2a clinical study

ILA Ann: ILA submits IND to US FDA for Phase 2a PEACH clinical trial

ILA Ann: Notice of Change of Auditor

ILA Ann: Island online investor briefing presentation

ILA Ann: IRB approval received for ISLA101 Phase 2a clinical trial

ILA Ann: ISLA101 drug product achieves stability milestone

ILA Ann: Island investor briefing invitation

ILA Ann: ISLA-101 trial update and investor presentation

ILA Ann: Island to present at World Antiviral Congress 2022

ILA Ann: Change in substantial holding

ILA Ann: Results of AGM

ILA Ann: Annual General Meeting MD Presentation

ILA Ann: ILA granted key Canadian patent for ISLA-101

ILA Ann: Positive analytical results for ISLA-101 capsules

ILA Ann: Island ShareCafe webinar presentation

ILA Ann: Quarterly Activity Report & Appendix 4C

ILA Ann: ISLA-101 manufacturing progress

ILA Ann: Annual Report to Shareholders

ILA Ann: Letter to Shareholders, Notice of AGM & Proxy Form

ILA Ann: Date of AGM & Closing Date for Director Nominations

ILA Ann: Appendix 4G

ILA Ann: Corporate Governance Statement

ILA Ann: Appendix 4E & Annual Report

ILA Ann: Appendix 3Y - David Foster

ILA Ann: Quarterly Activity Report & Appendix 4C

ILA Ann: Notification regarding unquoted securities - ILA

ILA Ann: Dr Amy Patick joins Island Scientific Advisory Board

ILA Ann: Appendix 3Y - David Foster

ILA Ann: Island to present at BIO International Convention

ILA Ann: ISLA-101 manufacturing and timeline update

ILA Ann: Change in substantial holding

ILA Ann: Quarterly Activity Report & Appendix 4C

ILA Ann: Updated Investor Presentation & Conference Participation

ILA Ann: Change in substantial holding

ILA Ann: Release of Securities from Escrow

ILA Ann: Appendix 4D & Half-Year Financial Statements

ILA Ann: Application for quotation of securities - ILA

Register to track ILA and receive email alerts.